ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0P48 Moberg Pharma Ab (publ)

30.45
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Moberg Pharma Ab (publ) LSE:0P48 London Ordinary Share SE0003613090 MOBERG PHARMA ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 30.45 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

New Number of Shares and Votes in Moberg Pharma AB (publ)

29/05/2020 7:13am

PR Newswire (US)


Moberg Pharma Ab (publ) (LSE:0P48)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Moberg Pharma Ab (publ) Charts.

STOCKHOLM, May 29, 2020 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announced that the total number of common shares in the company has increased to 19,223,510. The 370,000 newly issued shares are held by the company to secure its commitments under incentive programmes.

As per 29 May 2020, the total number of shares in Moberg Pharma AB (publ) amounts to 19,223,510. All shares are common shares. The total number of votes are 19,223,510. The increase in the number of shares and votes results from an issue of 370,000 class C shares. The newly issued class C shares have been repurchased and, by virtue of the conversion clause in the articles of association, converted to common shares. As per 29 May 2020 the company holds 554 746 common shares. The shares are intended to ensure fulfilment of commitments under incentive programmes.

For additional information, please contact:
Anna Ljung, CEO, telephone: +46-707-66-60-30, e-mail: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance, telephone: +46-76-805-82-88, e-mail: mark.beveridge@mobergpharma.se

About this information
The above information has been made public in accordance with the Swedish Financial Instruments Trading Act. The information was released for public distribution on 29 May 2020 at 8:00 am CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/moberg-pharma/r/new-number-of-shares-and-votes-in-moberg-pharma-ab--publ-,c3122534

The following files are available for download:

https://mb.cision.com/Main/1662/3122534/1255422.pdf

New number of shares and votes in Moberg Pharma AB (publ)

 

 

 

Cision View original content:http://www.prnewswire.com/news-releases/new-number-of-shares-and-votes-in-moberg-pharma-ab-publ-301067561.html

SOURCE Moberg Pharma

Copyright 2020 PR Newswire

1 Year Moberg Pharma Ab (publ) Chart

1 Year Moberg Pharma Ab (publ) Chart

1 Month Moberg Pharma Ab (publ) Chart

1 Month Moberg Pharma Ab (publ) Chart